» Articles » PMID: 34884909

Cardiac Remodeling and Repair: Recent Approaches, Advancements, and Future Perspective

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Dec 10
PMID 34884909
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The limited ability of mammalian adult cardiomyocytes to proliferate following an injury to the heart, such as myocardial infarction, is a major factor that results in adverse fibrotic and myocardial remodeling that ultimately leads to heart failure. The continued high degree of heart failure-associated morbidity and lethality requires the special attention of researchers worldwide to develop efficient therapeutics for cardiac repair. Recently, various strategies and approaches have been developed and tested to extrinsically induce regeneration and restoration of the myocardium after cardiac injury have yielded encouraging results. Nevertheless, these interventions still lack adequate success to be used for clinical interventions. This review highlights and discusses both cell-based and cell-free therapeutic approaches as well as current advancements, major limitations, and future perspectives towards developing an efficient therapeutic method for cardiac repair.

Citing Articles

Epicardial transplantation of antioxidant polyurethane scaffold based human amniotic epithelial stem cell patch for myocardial infarction treatment.

Li J, Yao Y, Zhou J, Yang Z, Qiu C, Lu Y Nat Commun. 2024; 15(1):9105.

PMID: 39438477 PMC: 11496666. DOI: 10.1038/s41467-024-53531-8.


Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases.

Li Q, Feng Q, Zhou H, Lin C, Sun X, Ma C MedComm (2020). 2023; 4(6):e454.

PMID: 38124785 PMC: 10732331. DOI: 10.1002/mco2.454.


Danhong Injection Up-regulates miR-125b in Endothelial Exosomes and Attenuates Apoptosis in Post-Infarction Myocardium.

Li S, Liu Z, Zhou M, Liu W, Lai X, Li P Chin J Integr Med. 2023; 29(12):1099-1110.

PMID: 37594702 DOI: 10.1007/s11655-023-3647-7.


Therapeutic Potential of EVs: Targeting Cardiovascular Diseases.

Laura Frances J, Pagiatakis C, Di Mauro V, Climent M Biomedicines. 2023; 11(7).

PMID: 37509546 PMC: 10377624. DOI: 10.3390/biomedicines11071907.


Single-cell and spatial transcriptomics: Advances in heart development and disease applications.

Long X, Yuan X, Du J Comput Struct Biotechnol J. 2023; 21:2717-2731.

PMID: 37181659 PMC: 10173363. DOI: 10.1016/j.csbj.2023.04.007.


References
1.
van Berlo J, Kanisicak O, Maillet M, Vagnozzi R, Karch J, Lin S . c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014; 509(7500):337-41. PMC: 4127035. DOI: 10.1038/nature13309. View

2.
Heallen T, Morikawa Y, Leach J, Tao G, Willerson J, Johnson R . Hippo signaling impedes adult heart regeneration. Development. 2013; 140(23):4683-90. PMC: 3833428. DOI: 10.1242/dev.102798. View

3.
Szaraz P, Gratch Y, Iqbal F, Librach C . In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells. J Vis Exp. 2017; (126). PMC: 5614219. DOI: 10.3791/55757. View

4.
Hasan A, Khattab A, Islam M, Hweij K, Zeitouny J, Waters R . Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction. Adv Sci (Weinh). 2016; 2(11):1500122. PMC: 5033116. DOI: 10.1002/advs.201500122. View

5.
Bicknell K, Coxon C, Brooks G . Can the cardiomyocyte cell cycle be reprogrammed?. J Mol Cell Cardiol. 2007; 42(4):706-21. DOI: 10.1016/j.yjmcc.2007.01.006. View